1. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial. Issue 1 (January 2015) Authors: Kaneko, Shizuka; Chow, Francis; Choi, Dong Seop; Taneda, Shinji; Hirao, Koichi; Park, Yongsoo; Andersen, Thomas Hasseriis; Gall, Mari-Anne; Christiansen, Jens Sandahl; on behalf of the BOOST®: Intensify All Trial Investigators Journal: Diabetes research and clinical practice Issue: Volume 107:Issue 1(2015) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗